Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuangcan Xionglian granules
- Development stage
- Unknown
- Lead developer
- Xiyuan Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Shuangcan Xionglian granules is a Traditional Chinese Medicine (TCM) compound formulation developed by the China Academy of Chinese Medical Sciences Xiyuan Hospital. It is primarily indicated for the treatment of stable angina pectoris in patients with coronary heart disease (CHD), specifically those presenting with the 'phlegm-blood stasis' syndrome (痰瘀互结证) according to TCM diagnostic criteria. The formulation is a botanical extract typically composed of herbs such as *Salvia miltiorrhiza* (Danshen), *Panax* species (Ginseng), *Ligusticum chuanxiong* (Chuanxiong), and *Coptis chinensis* (Huanglian). These ingredients are traditionally used to promote blood circulation, resolve blood stasis, and clear phlegm. In clinical trials, the granules are evaluated for their ability to improve myocardial ischemia, reduce anginal symptoms, and potentially modulate inflammatory and metabolic pathways associated with coronary artery disease.
- Other names
- Shuangcan Xionglian Keli
Beyond the preview
Go deeper on Shuangcan Xionglian granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shuangcan Xionglian granules.